CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression

被引:13
|
作者
McCloskey, TW
Oyaizu, N
Bakshi, S
Kowalski, R
Kohn, N
Pahwa, S
机构
[1] NYU, N Shore Univ Hosp, Sch Med, Dept Pediat,Div Allergy Immunol, Manhasset, NY 11030 USA
[2] NYU, N Shore Univ Hosp, Sch Med, Dept Res,Div Biostat, Manhasset, NY 11030 USA
来源
基金
美国国家卫生研究院;
关键词
CD95; apoptosis; HIV; infants;
D O I
10.1006/clin.1997.4496
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pediatric HIV infection is characterized by a progressive decline in CD4 T lymphocytes and faster disease progression than is typically seen in adults. Apoptosis, possibly mediated through the CD95 antigen, has been proposed as a mechanism for cell loss which eventually leads to immune dysfunction. In this study of peripheral blood lymphocytes from HIV-infected children, classified according to CDC immunologic categories, we found that the percentage of CD4 and CD8 T cells expressing CD95 and the percentage of lymphocytes undergoing apoptosis were increased in children with HIV infection and were greater in children from immunologic Category III as compared to those in Category I. Most striking was our observation that an increased percentage of CD95-positive cells appeared as early as 3 months of age, at a time when these children did not have elevated levels of apoptosis. These data demonstrate early upregulation of CD95 expression in HIV-infected infants, an abberation which may have profound implications for the pathogenesis of perinatally acquired IIIV disease. (C) 1998 Academic Press.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [1] Role of apoptosis and CD95/CD95 ligand expression in chronic hepatitis C and HIV infection
    Filipowicz, E
    Otolade, O
    Xiao, SY
    Adegboyega, PA
    MODERN PATHOLOGY, 2001, 14 (01) : 196A - 196A
  • [2] Role of apoptosis and CD95/CD95 ligand expression in chronic hepatitis C and HIV infection
    Filipowicz, E
    Ololade, O
    Xiao, SY
    Adeboyega, PA
    LABORATORY INVESTIGATION, 2001, 81 (01) : 196A - 196A
  • [3] CD95 and CD95 ligand expression in very thin melanoma
    Fearfield, LA
    Rowe, A
    Francis, N
    Fisher, C
    MacKie, RM
    Gore, ME
    Bunker, CB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 554 - 554
  • [4] Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
    Glick, RD
    Swendeman, SL
    Coffey, DC
    Rifkind, RA
    Marks, PA
    Richon, VM
    La Quaglia, MP
    CANCER RESEARCH, 1999, 59 (17) : 4392 - 4399
  • [5] Correlation of CD95 and soluble CD95 expression with acute rejection status of liver transplantation
    Wang, Yu-Liang
    Zhang, Yan-Yan
    Li, Guang
    Tang, Zhi-Qin
    Zhou, Yan-Li
    Zhu, Zhi-Jun
    Yao, Zhi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (11) : 1700 - 1704
  • [6] The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 549 - 559
  • [8] The role of CD95 and CD95 ligand in cancer
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (04): : 549 - 559
  • [9] Viral regulation of CD95 expression and apoptosis in T lymphocytes
    Sieg, S
    Huang, Y
    Kaplan, D
    JOURNAL OF IMMUNOLOGY, 1997, 159 (03): : 1192 - 1199
  • [10] Synergy of CD95 ligand and teniposide: No role of cleavable complex formation and enhanced CD95 expression
    Winter, S
    Roth, W
    Dichgans, J
    Weller, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 341 (2-3) : 323 - 328